158 related articles for article (PubMed ID: 6448264)
1. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol].
Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P
Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318
[TBL] [Abstract][Full Text] [Related]
3. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
[TBL] [Abstract][Full Text] [Related]
4. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
5. Testosterone-estradiol binding globulin (TeBG) in hirsute patients treated with cyproterone acetate (CPA) and percutaneous estradiol.
Vincens M; Mercier-Bodard C; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P
J Steroid Biochem; 1989 Oct; 33(4A):531-4. PubMed ID: 2530403
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta-estradiol.
Jasonni VM; Bulletti C; Naldi S; Di Cosmo E; Cappuccini F; Flamigni C
Fertil Steril; 1991 Apr; 55(4):742-5. PubMed ID: 1826278
[TBL] [Abstract][Full Text] [Related]
7. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
[TBL] [Abstract][Full Text] [Related]
8. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
Salva P; Morer F; Ordoñez J; Rodriguez J
Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
[TBL] [Abstract][Full Text] [Related]
9. [The mechanism of action of cyproterone acetate in the treatment of hirsutism].
Rigaud C; Vincens M; Mowszowicz I; Wright F; Mavier P; Nahoul K; Guillemant S; Kuttenn F; Mauvais-Jarvis P
Ann Endocrinol (Paris); 1983; 44(6):387-92. PubMed ID: 6234849
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
Porcile A; Gallardo E
Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
[TBL] [Abstract][Full Text] [Related]
11. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
Jones DB; Ibraham I; Edwards CR
Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
[TBL] [Abstract][Full Text] [Related]
12. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
13. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism].
Pugeat M; Nicolas MH; Déchaud H; Elmidani M
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798
[TBL] [Abstract][Full Text] [Related]
14. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
Lunell NO; Zador G; Carlström K; Eneroth P; Patek E; Wager J
Acta Endocrinol (Copenh); 1982 May; 100(1):91-7. PubMed ID: 6214134
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients.
Venturoli S; Ravaioli B; Bagnoli A; Colombo FM; Macrelli S; Iadarola I; Vianello F; Mancini F; Flamigni C
Eur J Contracept Reprod Health Care; 1998 Mar; 3(1):29-33. PubMed ID: 9678070
[TBL] [Abstract][Full Text] [Related]
16. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
Frey H; Aakvaag A
Acta Obstet Gynecol Scand; 1981; 60(3):295-300. PubMed ID: 6455899
[TBL] [Abstract][Full Text] [Related]
17. Increase in H-Y antigen-positive lymphocytes in hirsute women: effects of cyproterone acetate and estradiol treatment.
Amice V; Bercovici JP; Nahoul K; Hatahet MH; Amice J
J Clin Endocrinol Metab; 1989 Jan; 68(1):58-62. PubMed ID: 2521223
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Spona J; Huber J; Schmidt JB
Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
Ismail AA; Davidson DW; Souka AR; Barnes EW; Irvine WJ; Kilimnik H; Vanderbeeken Y
J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
[No Abstract] [Full Text] [Related]
20. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
